Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CYMER INC (CYMI)
|
Add to portfolio |
|
|
|
| Price: |
$41.57
| | Metrics |
| OS: |
31.6
|
M
| |
-7
|
% ROE
|
| Market cap: |
$1.31
|
B
| |
-9
|
% ROIC
|
|
Net cash:
|
$284
|
M
| |
$9.00
|
per share
|
|
EV:
|
$1.03
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($38.7)
|
M
| |
|
|
|
EBIT
|
($71.4)
|
M
| |
|
|
| EPS |
($1.81)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| Revenues | 538.6 | 594.2 | 534.2 | 307.7 | 459.0 | 521.7 | 543.9 | 383.6 |
| Revenue growth | -9.4% | 11.2% | 73.6% | -33.0% | -12.0% | -4.1% | 41.8% | -8.2% |
| Cost of goods sold | 252.5 | 289.1 | 261.4 | 171.3 | 240.8 | 260.3 | 281.2 | 227.3 |
| Gross profit | 286.1 | 305.1 | 272.8 | 136.4 | 218.2 | 261.4 | 262.6 | 156.4 |
| Gross margin | 53.1% | 51.4% | 51.1% | 44.3% | 47.5% | 50.1% | 48.3% | 40.8% |
| Sales and marketing | 23.7 | 25.1 | 22.7 | 16.6 | 23.7 | 26.2 | 30.6 | 25.1 |
| Research and development | 187.7 | 130.6 | 89.2 | 65.8 | 95.2 | 81.8 | 74.0 | |
| General and administrative | 51.7 | 41.8 | 39.8 | 27.6 | 36.2 | 38.9 | 38.9 | 26.5 |
| EBITA | -41.2 | 108.9 | 121.8 | 28.0 | 63.1 | 114.5 | 119.1 | 40.7 |
| EBITA margin | -7.6% | 18.3% | 22.8% | 9.1% | 13.8% | 21.9% | 21.9% | 10.6% |
| Amortization of intangibles | 1.4 | 1.3 | 0.7 | 1.6 | | | | |
| EBIT | -42.6 | 107.6 | 121.1 | 26.4 | 63.1 | 114.5 | 119.1 | 40.7 |
| EBIT margin | -7.9% | 18.1% | 22.7% | 8.6% | 13.8% | 21.9% | 21.9% | 10.6% |
| Pre-tax income | -43.3 | 108.4 | 121.1 | 17.1 | 50.3 | 129.9 | 138.7 | 45.8 |
| Income taxes | -6.9 | 28.2 | 30.3 | 8.4 | 16.6 | 44.4 | 46.1 | 0.3 |
| Tax rate | 16.0% | 26.0% | 25.0% | 49.0% | 33.0% | 34.2% | 33.3% | 0.6% |
| Net income | -36.4 | 80.2 | 90.7 | 5.5 | 30.8 | 88.4 | 95.6 | 46.6 |
| Net margin | -6.8% | 13.5% | 17.0% | 1.8% | 6.7% | 16.9% | 17.6% | 12.1% |
| |
| Diluted EPS | ($1.17) | $2.58 | $3.01 | $0.18 | $1.03 | $2.40 | $2.31 | $1.27 |
| Shares outstanding (diluted) | 31.1 | 31.1 | 30.1 | 29.9 | 30.0 | 36.8 | 41.4 | 36.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|